11 assets in Autonomic Nervous System Disorder

Therapeutic assets addressing Autonomic Nervous System Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carbidopa Autonomic Nervous System Disorder	Daniel Claassen	P1/2	CCC (54)
Droxidopa Autonomic Nervous System Disorder	Vanderbilt University Medical Center	P1/2	CCC (54)
Entacapone Autonomic Nervous System Disorder	Daniel Claassen	P1/2	CCC (54)
Fezolinetant Autonomic Nervous System Disorder	Shehzad Basaria, M.D.	P2	CCC (53)
Midodrine Autonomic Nervous System Disorder	Vanderbilt University Medical Center	P1	CCC (53)
FDOPA Autonomic Nervous System Disorder	Daniel Claassen	P1	CC (43)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Autonomic Nervous System Disorder	Zagazig University	N/A	D (30)
Dexmedetomidine Autonomic Nervous System Disorder	Zagazig University	N/A	D (30)